A new approach for Next Generation Sequencing in prenatal diagnosis applied to a case of Charcot-Marie-Tooth syndrome

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 1018-1021

  Dello Russo, Claudio ^a   Padula, Francesco ^a   Di Giacomo, Gianluca ^a   Mesoraca, Alvaro ^a   Gabrielli, Ivan ^a   Bizzoco, Domenico ^a   Giorlandino, Claudio ^a  

^a Artemisia Fetal Maternal Medical Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CASE REPORT; CHORION VILLUS SAMPLING; DNA EXTRACTION; FEMALE; FETUS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; MISSENSE MUTATION; MITOFUSIN 2 GENE; MUTATOR GENE; NEXT GENERATION SEQUENCING; PILOT STUDY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; CHARCOT-MARIE-TOOTH DISEASE; HIGH THROUGHPUT SEQUENCING; PREGNANCY; PROCEDURES;

CHARCOT-MARIE-TOOTH DISEASE; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84943351507     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4627     Document Type: Article

References (9)

1. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370(9):799-808, DOI:10.1056/NEJMoa1311037.
2. Lau TK, Cheung SW, Lo PSS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol, Off J Int Soc Ultrasound Obstet Gynecol 2014;43(3):254-64, DOI:10.1002/uog.13277.
3. Chitty LS, Mason S, Barrett AN, et al. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next generation sequencing allows for a safer, more accurate and comprehensive approach. Prenat Diagn 2015;35(7):656-62, DOI:10.1002/pd.4583.
4. Hill M, Twiss P, Verhoef TI, et al. Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat Diagn 2015;35(10):950-8, DOI:10.1002/pd.4585.
5. Filges I, Friedman JM. Exome sequencing for gene discovery in lethal fetal disorders-harnessing the value of extreme phenotypes. Prenat Diagn 2015;35(10):1005-9, DOI:10.1002/pd.4464.
6. Talkowski ME, Ordulu Z, Pillalamarri V, et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 2012;367(23):2226-32. DOI:10.1056/NEJMoa1208594.
7. Casasnovas C, Banchs I, Cassereau J, et al. Phenotypic spectrum of MFN2 mutations in the Spanish population. J Med Genet 2010;47(4):249-56. DOI:10.1136/jmg.2009.072488.
8. Vielhaber S, Debska-Vielhaber G, Peeva V, et al. Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol (Berl) 2013;125(2):245-56. DOI:10.1007/s00401-012-1036-y.
9. Bombelli F, Stojkovic T, Dubourg O, et al. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. JAMA Neurol 2014;71(8):1036-42. DOI:10.1001/jamaneurol.2014.629.